Status:
UNKNOWN
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
The Netherlands Cancer Institute
Sunnybrook Health Sciences Centre
Conditions:
Oncology
Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR...
Detailed Description
Rationale: Radiation therapy has become indispensable in cancer treatment. However, it is associated with severe side effects. Innovation in radiation therapy has resulted in the development of MR-gui...
Eligibility Criteria
Inclusion
- Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac;
- Patient provides written, informed consent;
- Patient is 18 years old or older.
Exclusion
- MRI exclusion criteria, including
- MRI contraindications as per usual clinical care, such as (possible) pregnancy; claustrophobia and metal or electronic implants not compatible with MRI.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT04075305
Start Date
February 1 2019
End Date
May 1 2025
Last Update
September 28 2023
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Allegheny Health Network
Pittsburgh, Pennsylvania, United States, 15212
2
Md Anderson Cancer Center
Houston, Texas, United States, 77030
3
Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226
4
Austin Health - Olivia Newton-John Cancer Wellness and Research Centre
Melbourne, Australia